Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 04, 2014 03:00 ET | Source: Pluri Inc.

Pluristem and Hadassah Medical Center Will Collaborate to Study Potential of PLX-RAD Cells to Improve Bone Marrow and Umbilical Cord Blood Transplant Outcomes

HAIFA, Israel, Dec. 4, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, announced today that it has entered...
December 01, 2014 03:00 ET | Source: Pluri Inc.

Pluristem Granted Patent in Singapore for Its 3D Cell Expansion Technology

HAIFA, Israel, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today it has been granted...
November 25, 2014 03:00 ET | Source: Pluri Inc.

Pluristem's Dr. Ohad Karnieli to Present at Two Upcoming Scientific Conferences

HAIFA, Israel, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that Dr. Ohad...
November 12, 2014 03:00 ET | Source: Pluri Inc.

Pluristem Granted Patents in Australia and New Zealand for Use of Placental Cells in the Treatment of Multiple Indications

HAIFA, Israel, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that it has been...
November 10, 2014 03:00 ET | Source: Pluri Inc.

Pluristem CEO Zami Aberman to Present at Two Regenerative Medicine Conferences in London on November 12 and 13, 2014

London Regenerative Medicine Network Meeting Alliance for Regenerative Medicine's 2nd Annual European Advanced Therapies Investor Day HAIFA, Israel, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Pluristem...
October 27, 2014 04:00 ET | Source: Pluri Inc.

Case Western Reserve University to Study Pluristem's PLX-RAD Cells in Umbilical Cord Blood Transplants for the Treatment of Blood Cancers and Genetic Diseases

HAIFA, Israel, Oct. 27, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-derived cell therapy products, announced today that researchers...
October 21, 2014 03:00 ET | Source: Pluri Inc.

Pluristem Advances Its Second Major Cell Therapy Product Line From Development to Large-Scale Manufacturing

HAIFA, Israel, Oct. 21, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, announced today that it has...
October 07, 2014 03:00 ET | Source: Pluri Inc.

Pluristem Wins Cell Therapy Patent Case in Europe; European Patent Office Confirms Validity of Amended Claims

HAIFA, Israel, Oct. 7, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, announced today that its European...
September 16, 2014 03:00 ET | Source: Pluri Inc.

Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market

HAIFA, Israel, Sept. 16, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, announced today it is evaluating...
September 10, 2014 03:00 ET | Source: Pluri Inc.

Pluristem to Deliver Scientific Presentations at 3rd International Placenta Stem Cell Society Meeting

HAIFA, Israel, Sept. 10, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, announced today that the Company's...